Refining Prognostic Predictions and Risk Assessment in Head and Neck Rhabdomyosarcoma
The Laryngoscope · 2025
DOI: 10.1002/lary.70200 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift The Laryngoscope, 2025. Verfasst von Yuan Zheng und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China. Hauptthemen laut MEDLINE: Head and Neck Neoplasms, Rhabdomyosarcoma. Die Arbeit nennt 41 Literaturangaben. Gefördert von: Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
Objective
This study aims to develop and validate prognostic models for predicting overall survival (OS) and disease‐specific survival (DSS) in patients with head and neck rhabdomyosarcoma (HNRMS), providing a practical tool for clinical decision‐making.
Methods
A retrospective cohort of patients diagnosed with HNRMS between 2000 and 2021 was analyzed. Prognostic factors were identified through Cox regression, and nomograms were constructed for survival. Model performance was rigorously assessed using the concordance index (C‐index), time‐dependent ROC curves, calibration curve, and decision curve analysis (DCA).
Results
A total of 1271 patients with HNRMS were included, with 889 patients in the training set and 382 in the validation set. The median OS was 16.9 months, and the median DSS was not reached. Advanced age, alveolar histology, para‐meningeal tumor location, distant metastasis, and lack of radiotherapy emerged as key adverse prognostic factors. The constructed nomograms demonstrated strong predictive performance, with C‐index values of 0.759 for OS and 0.743 for DSS in the training cohort, and 0.743 for OS and 0.730 for DSS in the validation cohort. Time‐dependent ROC analysis further confirmed the superior accuracy of the nomograms compared to traditional staging systems. Risk stratification classified patients into low‐, medium‐, and high‐risk groups, with 5‐year OS rates of 81.7%, 40.2%, and 12.0%, respectively, highlighting the model's clinical utility.
Conclusion
Our nomograms provide a highly accurate and clinically actionable tool for individualized prognostication in HNRMS, addressing the limitations of conventional staging systems. This advancement holds significant promise for personalized treatment strategies and improved patient outcomes. Level of Evidence 3.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
- Department of Medical Oncology, Qilu Hospital of Shandong University, Jinan, China.
- Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA.
- Medical Integration and Practice Center, Cheeloo College of Medicine, Shandong University, Jinan, China.
ORCID-Profile: Yuan Zheng, Jiaoyang Lu
Förderung
- Natural Science Foundation of Shandong Province
Zitieren
APA
Zheng, Y., Zhang, D., Sun, Q., & Lu, J. (2025). Refining Prognostic Predictions and Risk Assessment in Head and Neck Rhabdomyosarcoma. The Laryngoscope. https://doi.org/10.1002/lary.70200
Vancouver
Zheng Y, Zhang D, Sun Q, Lu J. Refining Prognostic Predictions and Risk Assessment in Head and Neck Rhabdomyosarcoma. The Laryngoscope. 2025. doi:10.1002/lary.70200
BibTeX
@article{Zheng2025,
author = {Zheng, Yuan and Zhang, Di and Sun, Qihao and Lu, Jiaoyang},
title = {Refining Prognostic Predictions and Risk Assessment in Head and Neck Rhabdomyosarcoma},
journal = {The Laryngoscope},
year = {2025},
doi = {10.1002/lary.70200}
}
EUVIMED